Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.96
-2.5306-1.23%
Volume:701.46K
Turnover:142.76M
Market Cap:10.28B
PE:32.16
High:204.65
Open:203.41
Low:201.98
Close:205.49
52wk High:217.12
52wk Low:138.79
Shares:50.65M
Float Shares:50.65M
Volume Ratio:1.57
T/O Rate:1.38%
Dividend:0.41
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.26
PE(LYR):-135.85

Loading ...

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

MT Newswires Live
·
2 hours ago

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
7 hours ago

Bank of America Reveals 5.22% Indirect Stake in Qiagen

TIPRANKS
·
18 hours ago

Amgen to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
19 hours ago

Exchange-Traded Funds, US Equities Fall After Midday

MT Newswires Live
·
22 hours ago

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Yesterday

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Yesterday

Sector Update: Healthcare Stocks Mixed Premarket Wednesday

MT Newswires Live
·
Yesterday

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Deep News
·
Yesterday

Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

TIPRANKS
·
Yesterday

Revvity to acquire Human Cell Design

TIPRANKS
·
Yesterday

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Yesterday

LIVE Markets-Europe Before the Bell: Eyeing Another Soft Open

Reuters
·
Yesterday

Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating

Stock News
·
Yesterday

Actinogen Medical Expands ASX-Quoted Share Base

TIPRANKS
·
Yesterday

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Yesterday

Money Quote: a Bad Day for Amgen Stock

Dow Jones
·
Yesterday

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday